A first-of-its-kind brain atlas. Researchers mapped 232,251 individual cells across four stages of development ...
And looking foolish may actually be good for your mental health. Here are three reasons why. Your brain is built to care what ...
Kavia AI, LLC announced that it has received a round of funding on September 10, 2026. The company has issued convertible preferred stock in the transaction. The transaction included participation ...
International advisory board brings together leading ALS researchers, clinicians, and nonprofit leaders to help guide ALS ...
Thailand asks 49 data centers to pause construction as regulators prepare new power, water, safety, and environmental rules.
nfvPPA, the type of frontotemporal dementia (FTD) most commonly associated with tau pathology, currently has no approved treatments in the United States or European Union ...
Frost & Sullivan officially unveils the 2026 Global Stem Cell Industry Development Blue Book, providing an in-depth analysis of the global stem cell industry. The report comprehensively examines the ...
Modern neurodegenerative disease research increasingly produces large and complex datasets. Genomics, transcriptomics, ...
Danish biotech Teitur Trophics completed its phase 1 study and said its experimental Parkinson's disease treatment TT-P34 was safe and reached the central nervous system, supporting plans to move the ...
CervoMed will present 12-week biomarker data from its Phase 2a trial of neflamapimod for nonfluent variant primary progressive aphasia (nfvPPA). The ISFTD Annual Meeting is scheduled for October 8-11, ...
In the brain, what matters is not only whether a signal reaches a nerve cell, but also how long its chemical gate remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results